bismuth subsalicylate 262 MG [Kaopectate Reformulated Aug 2006]

RxNorm concept 642347, branded drug component (sbdc).

RxCUI: 642347
Term type: Branded drug component (SBDC)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/642347 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

bismuth subsalicylate 19478

Related concepts

bismuth subsalicylate 262 MG Oral Tablet [Kaopectate Reformulated Aug 2006] (SBD, constitutes)
bismuth subsalicylate 262 MG Chewable Tablet [Kaopectate Reformulated Aug 2006] (SBD, constitutes)
Kaopectate Reformulated Aug 2006 (BN, has ingredient)
bismuth subsalicylate 262 MG (SCDC, tradename of)

Linked data

NDCs

RxNorm links no NDCs to this concept.

Use it

Look up 642347 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/642347 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 642347. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.